Navigation Links
Lung cancer conference to focus on new diagnostic techniques, potential treatments
Date:1/5/2012

SAN DIEGO -- Lung cancer is the most commonly diagnosed cancer in the United States and often the most fatal unless caught early, but scientists are working on ways to improve their understanding of the disease.

Several hundred of scientists will gather in San Diego at the San Diego Marriott Marquis & Marina during Jan. 8-11, 2012, for the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine.

The conference is jointly sponsored by the American Association for Cancer Research and the International Association for the Study of Lung Cancer.

Media are welcome to attend the conference and can register by contacting Jeremy Moore at Jeremy.Moore@aacr.org.

The conference will host a media briefing, entitled "Lung Cancer Diagnosis: Pitfalls, Challenges and the Path Ahead," on Tuesday, Jan. 10 at 1:00 p.m. PT (4:00 p.m. ET). The briefing will be held in the Atlanta/Chicago room of the San Diego Marriott Marquis & Marina.

The following leaders in lung cancer are scheduled to speak at the press conference:

  • Roy Herbst, M.D., Ph.D., chief of medical oncology and associate director for translational research at the Yale Cancer Center;
  • David P. Carbone, M.D., Ph.D., Harold L. Moses chair in cancer research, director of the Specialized Program of Research Excellence in Lung Cancer and co-leader of the Thoracic/Head and Neck Research Program at the Vanderbilt-Ingram Cancer Center; and
  • Paul A. Bunn, M.D., professor and James Dudley chair in cancer research at the University of Colorado School of Medicine.

Reporters who cannot attend in person can participate using the following information:

U.S./Canada (Toll Free): 888-647-7462

International (Toll): 201-604-0169

Conference leaders have also designated the following research as newsworthy:

  • Estrogen-Targeting Drug Combo May Help Prevent Lung Cancer
  • Researchers Map Potential Genetic Origins, Pathways of Lung Cancer in Never-Smokers
  • Ganetespib Showed Activity in KRAS-Mutant NSCLC as Monotherapy and in Combinations
  • Precancer Markers Identified in Airway Epithelium Cells of Healthy Smokers
  • Sorafenib Effective in Patients With Non-Small Cell Lung Cancer, but Low Survival Rates Reported
  • Sensitive Detection Method Analyzes Circulating Tumor Cells in Patients With Lung Cancer
  • Genetic Composition of Multicentric Lung Tumors Appears to be Similar


'/>"/>
Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. MU researchers photoacoustic device finds cancer cells before they become tumors
2. New stage in fighting pancreatic cancer
3. Gene identified in increasing pancreatic cancer risk
4. Cleveland Clinic researcher discovers genetic cause of thyroid cancer
5. Penn engineers develop more effective MRI contrast agent for cancer detection
6. Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers
7. Potential anti-cancer treatment method wins Kaye Award
8. Wayne State study finds soybean compounds enhances effects of cancer radiotherapy
9. Cancer from fetal exposure to carcinogens depends on dose, timing
10. AACR & IASLC to host molecular origins of lung cancer conference
11. London researchers lead innovative new cancer treatment study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/31/2019)... ... December 31, 2019 , ... Chelonian Conservation ... but researchers struggle to gather even basic information about this shy, burrowing reptile. ... used to identify individual animals, allowing agencies to monitor this threatened, federally protected ...
(Date:12/18/2019)... ... December 17, 2019 , ... ... enrollment of first patients in its U.S. Phase 3 study VISTA-2 building on ... compound in patients with moderate to severe Dry Eye Disease (DED). SkQ1 belongs ...
(Date:12/14/2019)... ... December 11, 2019 , ... Fiberstar, ... food and beverage industry won the 2019 Food Ingredient Europe’s plant-based innovation award. ... rapidly growing plant-based foods category. Fiberstar who was one of three finalists achieved ...
Breaking Biology News(10 mins):
(Date:1/7/2020)... ... January 07, 2020 , ... Vuja De Sciences (“Vuja De”), a biotechnology startup ... the appointments of Chand Khanna, DVM, PhD, DACVIM (Onc), and Dr. Lee Helman, MD, ... “We are delighted to welcome Chand and Lee as new directors. They will be ...
(Date:12/31/2019)... ... December 31, 2019 , ... ... pharmaceutical product development lab in Maryland. Emphasis will be in expanding ... expanded capabilities, Vici Health Sciences will be well positioned to meet the growing ...
(Date:12/27/2019)... ... December 27, 2019 , ... Vici Health ... 505(b)(2) product pipeline that offers patients and healthcare providers options in the ... identified in collaboration with doctors and managed care professionals and developed at Vici’s ...
(Date:12/18/2019)... ... December 18, 2019 , ... Tune in to CNBC ... by Ted Danson. Check local listings for more information on this program. , With ... reality are helping to simplify complex system to increase the efficiency, safety and effectiveness ...
Breaking Biology Technology: